Abstract P2-12-02: discovery of the β-catenin/Tcf inhibitors for treatment of triple negative breast cancer

MLA

Z.G. Wang, et al. “Abstract P2-12-02: Discovery of the β-Catenin/Tcf Inhibitors for Treatment of Triple Negative Breast Cancer.” Cancer Research, vol. 79, Feb. 2019, pp. P2-12. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs18-p2-12-02.

APA

Z.G. Wang, Ming Zhang, Hongkai Ji, & C Mo. (2019). Abstract P2-12-02: discovery of the β-catenin/Tcf inhibitors for treatment of triple negative breast cancer. Cancer Research, 79, P2-12. https://doi.org/10.1158/1538-7445.sabcs18-p2-12-02

Chicago

Z.G. Wang, Ming Zhang, Hongkai Ji, and C Mo. 2019. “Abstract P2-12-02: Discovery of the β-Catenin/Tcf Inhibitors for Treatment of Triple Negative Breast Cancer.” Cancer Research 79 (February): P2-12. doi:10.1158/1538-7445.sabcs18-p2-12-02.